Author
Dave Ricks
Dave Ricks is chair and chief executive officer of Eli Lilly and Company. He was elected chair of the company’s board effective June 2017.
Lilly CEO Dave Ricks' Letter to Shareholders: 2020 Integrated Summary Report
A Year into COVID-19, Science Delivers
Dave Ricks Shares About Lilly's FDA Emergency Use Authorization for a Neutralizing Antibody
CEO Dave Ricks Shares Lilly's Principles of COVID-19 Antibody Therapy Pricing and Access
Committing to the Indy Racial Equity Pledge
Amid COVID-19 Crisis, Lilly Introduces $35 Co-Pay for Insulin
To the Millions of Americans Who Rely on Lilly Insulin
Dave Ricks Shares Thoughts on 2019
Changing the Math on Alzheimer’s
A Catalyst for More Affordable Medicines